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Abstract
Proteins constituting the presynaptic machinery of vesicle release undergo substantial conformational changes during the
process of exocytosis. While changes in the conformation make proteins vulnerable to aggregation and degradation, little is
known about synaptic chaperones which counteract these processes. We show that the cell adhesion molecule CHL1
directly interacts with and regulates the activity of the synaptic chaperones Hsc70, CSP and aSGT. CHL1, Hsc70, CSP and
aSGT form predominantly CHL1/Hsc70/aSGT and CHL1/CSP complexes in synapses. Among the various complexes formed
by CHL1, Hsc70, CSP and aSGT, SNAP25 and VAMP2 induce chaperone activity only in CHL1/Hsc70/aSGT and CHL1/CSP
complexes, respectively, indicating a remarkable selectivity of a presynaptic chaperone activity for proteins of the exocytotic
machinery. In mice with genetic ablation of CHL1, chaperone activity in synapses is reduced and the machinery for synaptic
vesicle exocytosis and, in particular, the SNARE complex is unable to sustain prolonged synaptic activity. Thus, we reveal a
novel role for a cell adhesion molecule in selective activation of the presynaptic chaperone machinery.
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Introduction
Close homologue of L1 (CHL1), a cell adhesion molecule of the
immunoglobulin superfamily, regulates migration and differenti-
ation of neurons during ontogenetic development, and enhances
neuronal survival [1–6]. In mature neurons, CHL1 accumulates in
the axonal membrane and regulates clathrin-dependent synaptic
vesicle endocytosis [7]. The importance of CHL1 function is
underscored by studies showing multiple defects in neurotrans-
mission, long-term potentiation and behavior in CHL1 deficient
mice [8–12]. In humans, mutations in CHL1 (referred to as
CALL) are associated with reduced intelligence, mental retarda-
tion and occurrence of schizophrenia [13–17]. Prepulse inhibition
of the acoustic startle response, a measure of the ability of the
central nervous system to gate the flow of sensorimotor
information, and working memory, which are reduced in
schizophrenic patients, are also reduced in CHL1 constitutively
and conditionally deficient mice [8,10]. It remains unclear,
however, how mutations in CHL1 contribute to the development
of schizophrenia, the symptoms of which appear only in
adulthood, apparently weakening a direct link to CHL1-related
abnormalities in ontogenetic brain development and raising the
question whether CHL1 may relate more directly to synaptic
function.
We have observed a functional link in synaptic vesicle recycling
between CHL1 and the 70 kDa heat shock cognate protein
(Hsc70) [7], a constitutively expressed chaperone regulating
protein folding, transport and sorting [18,19]. Hsc70 prevents
aggregation and degradation of proteins, which transiently acquire
vulnerable non-native conformations [20]. In neurons, Hsc70
accumulates in presynaptic boutons and functions as an ATPase
that uncoates clathrin from clathrin-coated synaptic vesicles [21].
Since the chaperone activities of Hsc70 are regulated by its co-
chaperones we were interested in analyzing the relationship of
CHL1 with the co-chaperones of Hsc 70. Among them, the
cysteine string protein (CSP), expressed in the brain as aCSP
isoform (hereafter denoted CSP), is enriched in synaptic vesicles
and regulates neurotransmitter exocytosis [22–24]. Another co-
chaperone is the small glutamine-rich tetratricopeptide repeat-
containing protein (SGT) expressed as ubiquitous (aSGT) and
brain specific (bSGT) isoforms. CSP and SGT can directly and
simultaneously bind to Hsc70 and upregulate its activity in vitro
[25–26]. Supporting a role of Hsc70, CSP and SGT in protein
refolding in vivo, CSP deficient mice show progressive degeneration
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tor terminals [28] in early adulthood. We now show that CHL1
associates with presynaptic chaperones in the CHL1/Hsc70/
aSGT and CHL1/CSP complexes, the activities of which are
directed towards the SNARE complex.
Results
CHL1 deficiency results in abnormally reduced
chaperone activity in the brain
Having identified Hsc70 as a binding partner of the intracellular
domain of CHL1 [7], we were interested in analyzing whether
CHL1 deficiency affects chaperone activity in the adult brain.
Chaperone activity was estimated by measuring the efficiency of
the reactivation of an artificial substrate, denatured firefly
luciferase, in brain homogenates from wild type (CHL1+/+) and
CHL1 deficient (CHL12/2) mice. This method has been used
previously to study chaperone activity of Hsc70 and its co-
chaperones by measuring bioluminescence of the reactivated
luciferase [25,26]. Luciferase reactivation was reduced in
CHL12/2 versus CHL1+/+ brain homogenates (Fig. 1A).
Reduced luciferase reactivation in CHL12/2 brains was not
due to lower expression of Hsc70, since levels of Hsc70 were
upregulated in CHL12/2 brains [7]. Similarly to Hsc70, levels of
CSP [7] and aSGT (Fig. S2) were increased in CHL12/2 versus
CHL1+/+ brains.
To analyze whether CHL1 deficiency affects chaperone activity
in synapses, denatured luciferase was incubated with CHL1+/+ or
CHL12/2 synaptosomes or synaptic vesicles. Reactivation of the
luciferase was reduced in CHL12/2 versus CHL1+/+ probes
(Fig. 1A), indicating that chaperone activity is deficient in
CHL12/2 presynaptic boutons. Interestingly, addition of
recombinant Hsc70 did not increase but rather inhibited luciferase
reactivation in CHL12/2 synaptosomes (Fig. 1B). Reactivation
of luciferase activity was increased to CHL1+/+ levels when
CHL12/2 synaptosomes were preincubated with the intracellu-
lar domain of CHL1 (CHL1ID) (Fig. 1B). In contrast, the
intracellular domain of the cell adhesion molecule L1, extracellular
domain of CHL1 fused to Fc or Fc alone did not influence
luciferase reactivation in CHL12/2 synaptosomes (Fig. 1B).
Since CHL1ID has very low intrinsic protein refolding and
ATPase activity (Fig. S1), a plausible explanation for this
phenomenon is that CHL1ID activates chaperones, probably
including Hsc70.
CHL1 directly interacts with Hsc70, CSP and aSGT
To analyze whether CHL1 interacts with the co-chaperones of
Hsc70, co-immunoprecipitation experiments were carried out:
2362.1 and 4668.5% of the total pool of CSP and aSGT
molecules, respectively, co-immunoprecipitated with CHL1 from
brain lysates (Fig. 2A). In contrast, bSGT was not found in the
complex with CHL1 (Fig. 2A). Next, we tested whether
recombinant CHL1ID could be pulled down with recombinant
CSP, aSGT or bSGT, or Hsc70 used as positive control [7].
CHL1ID was pulled down not only with Hsc70 (Fig. 2B), but also
with CSP and aSGT, but not with bSGT (Fig. 2B). Thus, CHL1
directly interacts with CSP and aSGT and does not require Hsc70
as a linker.
CHL1/Hsc70 complex formation is important for accumula-
tion of Hsc70 in synaptic vesicles [7]. Similar to Hsc70, levels of
aSGT, but not bSGT, were reduced in synaptic vesicles and
synaptosomes from CHL12/2 mice (Fig. 2C, Fig. S2) although
levels of aSGT were increased in CHL12/2 brain homogenates
(Fig. S2). These observations implicate CHL1 in targeting not only
Hsc70, but also aSGT to presynaptic boutons and synaptic
vesicles. In contrast, CSP levels were increased in CHL12/2
versus CHL1+/+ synaptic vesicles (Fig. 2C), correlating with the
overall enhanced expression of CSP in CHL12/2 brain
homogenates [7]. CSP, then, appears to be targeted to synaptic
vesicles independently of CHL1, probably via palmitoylation of
cysteine residues [29].
CHL1 inhibits formation of the Hsc70/CSP/aSGT complex
by promoting formation of the CHL1/CSP and CHL1/
Hsc70/aSGT complexes
Since CHL1ID associates with the individual components of the
Hsc70/CSP/aSGT complex, we analyzed whether CHL1
associates with or influences formation of the Hsc70/CSP/aSGT
complex. Binding of CHL1ID, Hsc70, aSGT to CSP immobilized
on beads was analyzed under conditions when CHL1ID, Hsc70
and aSGT were present together in the incubation buffer. Since
nucleotides influence binding of CHL1ID to Hsc70 [7] and
formation of the trimeric Hsc70/CSP/aSGT complex [25],
interactions were analyzed in the presence of ADP or ATP. In
the absence of CHL1ID, Hsc70 and aSGT bound to CSP
(Fig. 3A). aSGT bound to CSP in a nucleotide-independent
manner, while Hsc70 bound to CSP more strongly in the presence
of ATP in accordance with a previous report [25]. CHL1ID
inhibited binding of aSGT to CSP in a nucleotide-independent
manner and totally blocked ATP-dependent binding of Hsc70 to
CSP by reducing it to the levels observed in the presence of ADP
(Fig. 3A). CHL1ID itself bound to CSP with more prominent
binding in the presence of ATP (Fig. 3A). Thus, an inhibitory
effect of CHL1ID on Hsc70/CSP/aSGT complex formation is
most probably due to binding of CHL1ID to individual
components of this complex and masking of sites required for
complex assembly. In agreement, CHL1ID and CSP bind to
Hsc70 via similar HPD tripeptide based motifs [7,30], and may
compete with each other for binding to Hsc70 (Fig. 3F).
To further analyze the mechanism, by which CHL1 inhibits
formation of the Hsc70/CSP/aSGT complex, we attempted to
identify binding sites within CHL1ID for Hsc70, CSP, and aSGT.
Fragments of CHL1ID that either contained the membrane
adjacent portions of CHL1ID of different lengths ranging from 25
to 85 amino acids or the whole CHL1ID without the membrane
proximal 25 amino acid stretch, were immobilized on beads and
assayed for their ability to pull down Hsc70, CSP or aSGT. All
membrane proximal fragments of CHL1ID bound to Hsc70 and
CSP, but not to aSGT (Fig. 3B), suggesting that Hsc70 and CSP
bind to closely located sequences within the 25 amino acid stretch
containing the HPD tripeptide. Thus CSP bound to CHL1ID
would sterically interfere with the interaction between CHL1ID
and Hsc70 (Fig. 3E). In contrast, deletion of the C-terminal 19
amino acid stretch of CHL1ID abolished the interaction between
CHL1ID and aSGT (Fig. 3B), suggesting that this fragment
contains the binding site for aSGT. Confirming this finding, the
CHL1ID fragment without the membrane adjacent 25 amino acid
stretch bound to aSGT, but not to Hsc70 and CSP (Fig. 3B).
To investigate the composition of CHL1-containing protein
complexes in synapses we separated protein complexes in synaptic
vesicles and synaptic plasma membranes by PAGE under non-
denaturing conditions and analyzed them by Western blot. This
analysis showed that in synaptic vesicles CHL1 co-migrated with
Hsc70, CSP, and aSGT predominantly in trimeric CHL1/
Hsc70/aSGT and dimeric CHL1/CSP combinations (Fig. 3C,F).
Only low levels of the CHL1/CSP complex were found in
synaptic plasma membranes, while this fraction was enriched in
the CHL1/Hsc70/aSGT complex (Fig. 3D,F). Tetrameric
CHL1 and Synaptic Chaperones
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plexes were not detectable in either fraction (Fig. 3C,D).
CHL1 enhances chaperone activity of Hsc70/aSGT and
CSP
To investigate whether CHL1-containing chaperone complexes
possess chaperone activity, we studied reactivation of denatured
luciferase by Hsc70/aSGT and CSP either in the presence or
absence of CHL1ID. Reactivation of luciferase was increased in
the presence of CHL1ID (Fig. 3E) suggesting that CHL1ID
promotes chaperone activity.
Hsc70/CSP/aSGT has been reported to possess the highest
chaperone activity when compared to Hsc70, CSP and aSGT
alone [25]. Pre-incubation of this complex with CHL1ID also
resulted in increased luciferase reactivation (Fig. 3E). Since
CHL1ID induces disassembly of Hsc70/CSP/aSGT into
CHL1/Hsc70/aSGT and CHL1/CSP (Fig. 3F), these observa-
tions indicate that formation of CHL1/Hsc70/aSGT and CHL1/
Figure 1. Chaperone activity is reduced in CHL12/2 brains. A - Graphs show mean levels of activity 6 SEM (n=6) of luciferase reactivated in
CHL1+/+ or CHL12/2 brain homogenates, synaptosomes, or synaptic vesicles normalized to activity levels of native luciferase set to 100%. The
probes used for luciferase reactivation assay were probed by Western blot with antibodies against CHL1 and actin (homogenates) or synaptophysin
(synaptosomes and synaptic vesicles). Similar levels of actin and synaptophysin in the probes indicate similar total protein levels. Reactivation of
luciferase is reduced in CHL12/2 probes. *p,0.05, paired t-test. B - Graph shows mean levels of activity 6 SEM (n=6) of luciferase reactivated in
CHL1+/+ or CHL12/2 synaptosomes, or in CHL12/2 synaptosomes pre-incubated with recombinant CHL1 intracellular domain (CHL1ID), L1
intracellular domain (L1ID), CHL1 extracellular domain fused to Fc (CHL1-Fc), Fc alone or Hsc70. Values were normalized to activity levels of native
luciferase set to 100%. Reactivation of luciferase in CHL12/2 synaptosomes pre-incubated with CHL1ID is increased. *p,0.05, repeated measures
ANOVA (Dunnett’s multiple comparison test, compared to all other CHL12/2 probes).
doi:10.1371/journal.pone.0012018.g001
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that of Hsc70/CSP/aSGT complex.
CHL1 associates with the SNARE complex proteins
Further analysis showed that the CHL1/Hsc70/aSGT-con-
taining band observed under non-denaturing conditions over-
lapped with the SNAP25-immunoreactive band in synaptic
vesicles and synaptic plasma membranes (Fig. 3C,D). In contrast,
the CHL1/CSP-containing band overlapped with the VAMP2-
immunoreactive band in synaptic vesicles (Fig. 3C), but not in
synaptic plasma membranes (Fig. 3D). In agreement, analysis of
CHL1 immunoprecipitates from brain lysates by Western blot
with antibodies against the SNARE complex proteins showed that
1766.8%, 1563.1%, 22611.9% of the total pool of the SNARE
complex proteins SNAP25, syntaxin1B, and VAMP2, respectively,
co-immunoprecipitated with CHL1 (Fig. 4A). Another synaptic
vesicle associated protein, synaptophysin, did not co-immunopre-
cipitate with CHL1 (Fig. 4A).
The interaction between CHL1 and SNAP25 or syntaxin1B,
however, was not detectable in synaptosomes isolated from brain
tissue (Fig. 4B) suggesting that the CHL1/SNAP25 and CHL1/
syntaxin1B complexes detectable in brain homogenates are from
extrasynaptic compartments. Since SNARE proteins redistribute
to extrasynaptic sites following synapse activation [31], we
analyzed whether interactions between CHL1 and the SNARE
complex proteins depend on synaptic activity by treating
synaptosomes for 90 s with a buffer containing 47 mM K+ to
depolarize synaptic plasma membranes and induce synaptic
vesicle exo- and endocytosis. Western blot analysis of CHL1
immunoprecipitates from stimulated synaptosomes showed that
SNAP25 and syntaxin1B co-immunoprecipitated with CHL1 from
synaptosomes activated with 47 mM K+ (Fig. 4B). The extent of
this co-immunoprecipitation was increased in synaptosomes
repetitively stimulated with 47 mM K+ with short intervals of
recovery in 4 mM K+ (Fig. 4B), suggesting that synaptic vesicle
recycling triggers formation of the CHL1/SNAP25 and CHL1/
syntaxin1B complexes. In contrast to SNAP25 and syntaxin1B, the
association of CHL1 with VAMP2 was strongest in non-stimulated
synaptosomes and diminished following stimulation with 47 mM
K+ (Fig. 4B).
Interestingly, CHL1ID showed low binding to purified SNAP25
or VAMP2 immobilized on plastic (Fig. 4C). Binding of CHL1ID
was enhanced, however, when SNAP25 and VAMP2 were
exposed to 42uC (Fig. 4C) to induce non-native conformations
(see below). Thus, the affinity of CHL1ID to SNARE proteins
appears to depend on their conformation, and acquisition of non-
native conformations by SNARE proteins during synaptic vesicle
recycling may account for the increased association of CHL1ID
with these proteins in stimulated versus non-stimulated synapto-
somes. The fact that CHL1ID interacts preferentially with non-
native SNARE proteins may also account for relatively low co-
immunoprecipitation efficiency of these proteins with CHL1.
CHL1/CSP and CHL1/Hsc70/aSGT complexes chaperone
SNARE complex components
To obtain insights into the role of the interactions between
CHL1 and the SNARE complex proteins, we analyzed whether
SNARE complex proteins can activate CHL1-containing chaper-
one complexes under conditions close to physiological. Recombi-
nant SNAP25 and VAMP2 were exposed to 42uC for 10 min in
the presence of high concentrations of bivalent ions which can be
found in highly active synaptic boutons. We have deliberately
chosen conditions, which are close to those in diseased or highly
stressed organisms, since mutations in CHL1 are associated with
stress related disorders such as schizophrenia. Since ATPase
activity of chaperones is directly linked to chaperoning of the
substrate proteins and thus can serve as a marker of the chaperone
activity, ATPase activity of CHL1-containing complexes was
analyzed by estimating levels of inorganic phosphate released from
ATP by these complexes in the presence of heat-treated SNAP25
and VAMP2. ATPase activity was always compared to the basal
ATPase activity in the presence of native SNAP25 and VAMP2,
which had not been exposed to heat.
Analysis of ATPase activity of CHL1ID, Hsc70, CSP and
aSGT alone or various combinations of these proteins showed that
heat-treated VAMP2 specifically increased ATPase activity of only
the CHL1ID/CSP complex, with ATPase activity of this complex
being ,3 times higher in the presence of heat-treated versus native
VAMP2 (Fig. 5A). These observations are in agreement with
previous reports showing that CSP possesses Hsc70-independent
chaperone activity both in vitro and in vivo [30,32]. In contrast,
heat-treated SNAP25 activated only the CHL1ID/Hsc70/aSGT
complex, with ATPase activity of this complex being ,2 times
higher in the presence of heat-treated versus native SNAP25
(Fig. 5A). A slight, but significant increase in ATPase activity in the
presence of heat-treated SNAP25 was also observed for the
Hsc70/aSGT combination (Fig. 5A). These data indicate that
SNAP25 and VAMP2 are not only able to acquire non-native
chaperone-activating conformations, but also suggest a high
specificity in their interactions with the chaperones.
Interestingly, non-native SNAP25 inhibited the basal ATPase
activity of CSP alone or in combination with CHL1ID (Fig. 5A). A
plausible explanation for this finding is that SNAP25 inhibits the
chaperone activity of CSP during synaptic vesicle exocytosis, when
surface plasma membrane enriched SNAP25, which unfolds
during fusion of synaptic vesicle with surface membranes, is in
the vicinity of synaptic vesicle localized CSP. This inhibition may
then be required to allow VAMP2 to change its conformation for
synaptic vesicle exocytosis. None of the chaperone complexes was
activated in the presence of heat-treated synaptophysin (Fig. 5A).
Next we assessed binding of recombinant SNAP25 and VAMP2
to synatxin1B immunopurified from mouse brains. Non-treated
SNAP25 and VAMP2 bound syntaxin1B immobilized on beads
(Fig. 5B). When either SNAP25 or VAMP2 were pre-exposed to
42uC for 10 min, binding of both proteins was strongly reduced
Figure 2. CHL1 interacts with Hsc70, CSP and aSGT. A - CHL1 immunoprecipitates (IP) from brain lysates and input material were probed with
antibodies against CSP, aSGT and bSGT by Western blot. Mock IP with non-specific immunoglobulins (Ig) was performed for control. CSP and aSGT,
but not bSGT co-immunoprecipitated with CHL1. B - GST and GST-tagged Hsc70, CSP, aSGT, bSGT immobilized on beads were assayed for their
ability to pull down CHL1ID. Coomassie blue stained gels show that levels of Hsc70, CSP, aSGT and bSGT immobilized on beads were similar or lower
than levels of GST on control beads. Lower molecular weight products of the recombinant proteins derive from degradation. CHL1ID was pulled
down with Hsc70, CSP and aSGT, but not with GST or bSGT. Input shows levels of CHL1ID taken for the pull down assay. C - CHL1+/+ and CHL12/2
synaptic vesicles were probed by Western blot with the indicated antibodies. Graphs show mean optical density of the protein bands in CHL12/2
synaptic vesicles 6 SEM (n=6) normalized to the optical density in CHL1+/+ set to 100%. Levels of Hsc70 and aSGT are decreased while levels of CSP
are increased in CHL12/2 synaptic vesicles. Levels of bSGT are similar in both genotypes. Synaptophysin (synapt.) served as a loading control.
*p,0.05, paired t-test (when compared to CHL1+/+ level (solid line)).
doi:10.1371/journal.pone.0012018.g002
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Binding of non-treated SNAP25/heat-treated VAMP2 to synat-
xin1B was restored when heat-treated VAMP2 was pre-incubated
with the CHL1ID/CSP complex, but not with the CHL1ID/
Hsc70/aSGT complex (Fig. 5B). In contrast, binding of heat-
treated SNAP25/non-treated VAMP2 was restored when heat-
treated SNAP25 was pre-incubated with the CHL1ID/Hsc70/
aSGT complex, but not with the CHL1ID/CSP complex (Fig. 5B).
Combined observations indicate that VAMP2 and SNAP25 are
substrates for two distinct chaperone complexes, CHL1/CSP and
CHL1/Hsc70/aSGT, respectively, suggesting that these chaper-
ones could assist VAMP2 and SNAP25 in assembly of the SNARE
complex.
CHL1ID/Hsc70/aSGT and CHL1ID/CSP chaperone
complexes dissolve aggregates formed by non-native
SNAP25 and VAMP2
To gain insights into the functions of the CHL1-containing
chaperones, we analyzed changes in the structures of SNAP25 and
VAMP2 following thermal exposure. Circular dichroism (CD)
spectroscopy showed that SNAP25 and VAMP2 are proteins
largely composed of random coil structure (Fig. 6A) as observed
previously [33,34]. In solution, both proteins are characterized by
hydrodynamic radii of 5.260.5 nm (SNAP25) and 5.660.3 nm
(VAMP2), as revealed by dynamic light scattering (DLS)
measurements (Fig. 6B). For monomeric SNAP25 (Mw=23315
Da) and VAMP2 (Mw=12690 Da), hydrodynamic radii of
2.15 nm and 1.76 nm, respectively, are expected, assuming a
roughly globular shape [35]. However, the undefined random coil
structure of both proteins strongly decreases the diffusion of the
molecules in solution, resulting in a significantly increased
apparent hydrodynamic radius. On the other hand, the formation
of small oligomeric states can not be excluded. When SNAP25 and
VAMP2 were exposed to 42uC for 10 min, the secondary
structure of the proteins was not affected significantly, as revealed
by almost identical CD spectra. Only marginal shifts of the
predominant minima towards 200 nm with respect to the spectra
for native proteins have been observed that could indicate minor
changes in the protein conformation (Fig. 6A). Remarkably,
exposure to 42uC resulted in a pronounced aggregation of
SNAP25 and VAMP2 reflected by formation of large assemblies
with hydrodynamic radii of ,1 mm (1134.306191.47 nm for
SNAP25 and 904.126142.90 nm for VAMP2) as measured by
DLS (Fig. 6B). This observation suggested that heat treatment
induced acquisition of non-native conformations by both SNAP25
and VAMP2, which cannot be detected by CD spectroscopy.
When non-native SNAP25 was incubated with the CHL1ID/
Hsc70/aSGT complex in the presence of ATP, these large
assemblies were partially dispersed, resulting in particles with a
radius of 171.05615.87 nm, probably representing complexes of
SNAP25 and chaperones (Fig. 6B). In contrast, assemblies of non-
native SNAP25 were not dispersed by the CHL1ID/Hsc70/
aSGT complex in the absence of nucleotides or in the presence of
ADP, or by the CHL1ID/CSP complex in the presence of ATP.
Similarly, when non-native VAMP2 was incubated with the
CHL1ID/CSP complex in the presence of ATP, VAMP2
aggregates were partially dispersed forming assemblies with a
radius of 150.00630.41 nm (Fig. 6B). In contrast, aggregates of
non-native VAMP2 were not dispersed by the CHL1ID/CSP
complex in the absence of nucleotides or in the presence of ADP,
or by the CHL1ID/Hsc70/aSGT complex in the presence of
ATP.
The combined data indicate that CHL1ID/Hsc70/aSGT and
CHL1ID/CSP complexes specifically disperse aggregates formed
by non-native SNAP25 and VAMP2, respectively.
CHL1 deficiency results in increased degradation of the
SNARE complex proteins in response to stress
Incorrect folding and aggregation result in protein degradation
by cellular proteases [36,37]. Thus, an analysis of protein
Figure 3. CHL1 recruits Hsc70 and aSGT to synaptic vesicles but inhibits their association with CSP by forming dimeric CHL1/CSP
and trimeric CHL1/Hsc70/aSGT complexes. A - GST and GST-tagged CSP immobilized on beads were assayed for their ability to pull down
Hsc70 and aSGT from a mixture of these proteins in the presence of ADP or ATP with or without CHL1ID. Graphs show mean optical density of the
blots 6 SEM (n=6). For quantitation of the binding of Hsc70 and aSGT to CSP (graphs on the left and in the middle, respectively), levels of these
proteins bound to CSP in the presence of ADP and absence of CHL1ID were set to 100%. For quantitation of the binding of CHL1ID to CSP (graph on
the right), levels of CHL1ID bound to CSP in the presence of ADP were set to 100%. Note that in the presence of ATP, CHL1ID binds to CSP with
higher efficiency than in the presence of ADP. CHL1ID inhibits aSGT/CSP complex formation in a nucleotide independent manner and inhibits ATP-
dependent formation of the Hsc70/CSP complex. *p,0.05, paired t-test (compared as indicated). B - Scheme (top) shows CHL1ID fragments marked
alphabetically that were immobilized on beads via the GST tag and assessed for their ability to pull down Hsc70, CSP or aSGT. Coomassie blue stained
gel shows that similar levels of CHL1 fragments were immobilized on beads. Lower molecular weight degradation products of the recombinant
proteins are also observed. Binding of Hsc70, CSP and aSGT to CHL1ID fragments was analyzed by Western blot with the corresponding antibodies.
Note that amino acids 1105–1130 within CHL1ID are necessary to bind Hsc70 and CSP, while amino acids 1190–1209 are necessary to bind aSGT.
Double bands recognized by CSP antibodies represent oligomeric forms of recombinant CSP as described previously [51]. C,D - Molecular complexes
in synaptic vesicles (C) and synaptic plasma membranes (D) were separated by PAGE under non-denaturing conditions and probed by Western blot
with the indicated antibodies. Two or more proteins were considered in a presumed complex, if their bands in the gel overlapped at the apparent
molecular weight calculated to be equal or above the total molecular weight of the sum of the weights of the proteins together. In accordance with
this criterion, arrows show overlapping bands of CHL1, Hsc70, and aSGT that presumably represent the CHL1/Hsc70/aSGT complex. Note that CHL1/
Hc70/aSGT complex migrates at the two levels in the native gel probably due to the multimerization of its components or presence of additional
binding partners in the slower migrating level (black arrows) compared to faster migrating level (grey arrows). The higher molecular weight level is
more evident in synaptic vesicles, while lower molecular weight level is more evident in synaptic plasma membranes. Arrowheads show overlapping
bands of CHL1 and CSP that presumably represent the CHL1/CSP complex. Only complexes of CHL1 together with Hsc70, CSP or aSGT are marked.
Note that trimeric Hsc70/CSP/aSGT complexes are not detectable in the gels since CSP bands do not overlap with aSGT bands. In D, a CHL1 band
overlapping with Hsc70 and CSP immumoreactive bands at ,230 kDa may contain only the CHL1/CSP complex of ,230 kDa but not CHL1/Hsc70/
CSP or CHL1/Hsc70 complexes with molecular weights above 250 kDa. Note SNAP25 and VAMP2 positive bands, which overlap with CHL1/Hsc70/
aSGT and CHL1/CSP complexes, respectively. In synaptic plasma membranes, VAMP2 accumulates in a high molecular weight complex with a slightly
different molecular weight than that of the CHL1/Hsc70/aSGT complex. E - Graphs show mean levels of activity 6 SEM (n=6) of luciferase reactivated
by indicated combinations of chaperones. Values were normalized to luciferase reactivation levels in the absence of the added CHL1ID set to 100%.
*p,0.05, paired t-test. F - Schematic model diagram of CHL1-containing chaperone complexes. The Hsc70/CSP/aSGT complex dissociates into the
CHL1/CSP complex present in synaptic vesicles and the CHL1/Hsc70/aSGT complex present in synaptic vesicles and plasma membranes. HPD
tripeptides within the intracellular domain of CHL1 and the J-domain of CSP are marked in yellow.
doi:10.1371/journal.pone.0012018.g003
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chaperones. Exposure to 30uC, i.e. a temperature which is even
lower than the one used in the in vitro assay, induced a pronounced
degradation of SNARE complex proteins in CHL12/2 brain
homogenates, while only mildly affecting levels of these proteins in
CHL1+/+ brain homogenates (Fig. 7).
We next analyzed whether synaptic activity influences the levels
of the SNARE complex proteins. CHL1+/+ and CHL12/2
cultured hippocampal neurons were treated for 30 min with
50 mM picrotoxin (PTX), an inhibitor of GABAA receptors that
induces seizure-like activity in neurons. Western blot analysis of
cell lysates of these cultures showed that levels of SNAP25 and
VAMP2, but not synaptophysin were strongly reduced in PTX-
treated versus non-treated CHL12/2 neurons (Fig. 8). PTX
stimulation did not affect the SNARE complex protein levels in
CHL1+/+ neurons (Fig. 8). However, levels of VAMP2 and
syntaxin1B were increased in stimulated CHL1+/+ neurons,
probably due to enhanced synthesis of these proteins. Although
levels of syntaxin1B were not changed in PTX-treated versus non-
treated CHL12/2 neurons, they were lower than the levels of
syntaxin1B in PTX-treated CHL1+/+ neurons (Fig. 8). These
results again suggest higher degradation of syntaxin1B in activated
CHL12/2 neurons when compared to CHL1+/+ neurons. We
cannot exclude, however, that synthesis of the SNAP25, syntaxin
1B and VAMP2 in response to PTX stimulation is also affected by
CHL1 deficiency. PTX treatment was not associated with
enhanced apoptosis in CHL12/2 neurons as indicated by
unchanged levels of active caspase-3 in stimulated versus non-
stimulated neurons of both genotypes (Fig. 8). Levels of Hsc70,
CSP and aSGT were also not affected by PTX stimulation in both
genotypes (Fig. 8). Thus, our data indicate that CHL1 deficiency
results in enhanced susceptibility of the synaptic vesicle fusion
machinery to stressful conditions, such as high synaptic activity.
Aggregation and degradation of the SNARE complex
proteins are increased in CHL12/2 mice
We next analyzed whether abnormal SNARE protein aggrega-
tion can be detected in CHL12/2 mice. Protein aggregates were
isolated from the total protein pool of CHL1+/+ and CHL12/2
brains by means of centrifugation. Western blot analysis showed
that ,20% and 10% of VAMP2 and SNAP25, respectively, were
present as aggregates in CHL1+/+ brain homogenates (Fig. 9A).
The levels of aggregated VAMP2 and SNAP25 were ,2 fold
higher in CHL12/2 brain homogenates (Fig. 9A). The levels of
Figure 4. CHL1 interacts with SNARE complex proteins. A - CHL1
immunoprecipitates (IP) from brain lysates and input material were
probed with the indicated antibodies by Western blot. Mock IP with
non-specific rabbit immunoglobulins (Ig) was performed for control.
SNAP25, syntaxin1B, and VAMP2, but not synaptophysin co-immuno-
precipitated with CHL1. B - CHL1 was immunoprecipitated (IP) from
synaptosomes that were mock-stimulated with 4 mM K+, or stimulated
one or two times with 47 mM K+ for 90 s with or without 5 min
recovery in 4 mM K+ after stimulations (as indicated). CHL1 immuno-
precipitates and input material were then probed by Western blot with
indicated antibodies. Mock IP with non-specific immunoglobulins (Ig)
was performed for control. Note that no co-immunoprecipitation of
SNAP25 and syntaxin 1B with CHL1 is observed in mock-stimulated
synaptosomes even after high exposure of the blots. Stimulation
induces co-immunoprecipitation of SNAP25 and syntaxin1B, and
decreases levels of co-immunoprecipitated VAMP2. C -C H L 1 I D
(1.9 mM) was immobilized on plastic and assayed by ELISA for the
ability to bind SNAP25 (4 mM) and VAMP2 (6 mM) either in native form
(N) or after exposure to 42uC (H). CHL1ID binds stronger to non-native
SNAP25 and VAMP2. *p,0.05, paired t-test (n=6).
doi:10.1371/journal.pone.0012018.g004
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PLoS ONE | www.plosone.org 8 August 2010 | Volume 5 | Issue 8 | e12018Figure 5. SNARE complex proteins selectively activate the chaperone activity of CHL1-containing chaperone assemblies. A - Graphs
show mean levels 6 SEM of free inorganic phosphate (Pi) released from ATP (ATPase activity) by the indicated combinations of Hsc70, CSP, aSGT, and
CHL1ID in response to native or heat-treated non-native SNAP25, VAMP2, or synaptophysin. The complete list of all tested combinations of CHL1ID,
Hsc70, CSP, and aSGT is shown in Table S1. Note that non-native SNAP25 and VAMP2 activate ATPase activity of CHL1ID/Hsc70/aSGT and CHL1ID/
CSP complexes, respectively. *p,0.05, paired t-test (compared to the ATPase activity in the presence of native proteins set to 100% (n$6)). B -
Syntaxin1B was immunoprecipitated from synaptosomes and assayed for the ability to pull down heat-treated non-native (H) or native (N) SNAP25
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genotype (Fig. 9A). No detectable aggregates of GAPDH were
found in either genotype (Fig. 9A).
The levels of SNAP25 and VAMP2 were also increased in
lysosomes isolated from CHL12/2 brains (Fig. 9B), suggesting
increased targeting for degradation. Syntaxin 1B levels were only
slightly increased in CHL12/2 lysosomes, while levels of the cell
adhesion molecule L1, which served as a loading control, were
similar in both genotypes (Fig. 9B).
CHL1 deficiency is associated with reduced reassembly of
the SNARE complex components and inhibition of
synaptic vesicle recycling following prolonged and
stressful synapse activity
To investigate whether the ability to reassemble the SNARE
complex is affected by CHL1 deficiency, we analyzed co-
immunoprecipitations of SNAP25 and VAMP2 with syntaxin1B
from synaptosomes. SNAP25 and VAMP2 co-immunoprecipitat-
ed with syntaxin1B with a similar or slightly higher efficiency from
non-stimulated CHL12/2 versus CHL1+/+ synaptosomes
(Fig. 10A). However, following stimulation of synaptosomes for
90 s with 90 mM K+ to induce synaptic vesicle exo- and
endocytosis, the ability of VAMP2 and SNAP25 to associate with
syntaxin1B was reduced in CHL12/2 synaptosomes by ,25%
compared to non-stimulated CHL12/2 synaptosomes (Fig. 10A).
These data indicate that CHL1 deficiency results not only in
enhanced degradation of SNARE complex proteins, but also in
reduced ability of these proteins to re-associate in the SNARE
complex following synaptic vesicle exocytosis.
To assess the impact of prolonged synaptic activity on the
synaptic vesicle recycling machinery, we analyzed activity-
dependent uptake of the lipophilic fixable dye FM1-43FX to
synaptic boutons, visualized by post-hoc immunofluorescence with
antibodies against the synaptic vesicle protein SV2. Uptake of
FM1-43FX applied in the presence of 50 mM PTX to induce
synaptic vesicle exo- and endocytosis was slightly reduced in
CHL12/2 versus CHL1+/+ neurons (Fig. 10B). Preincubation of
neurons with 50 mM PTX for 30 min before application of the dye
further reduced FM1-43FX uptake in CHL12/2 but not in
CHL1+/+ synaptic boutons (Fig. 10B). Similar results were
obtained when synaptic vesicle recycling was visualized in real
time imaging using live neurons transfected with VAMP2-
pHluorin, an optical probe for synaptic vesicle exo- and
endocytosis: repetitive stimulation with high K+ concentrations
resulted in an inhibition of the recycling response to the second
stimulus in CHL12/2 but not CHL1+/+ neurons (Fig. S3). The
results thus indicate that the synaptic vesicle recycling machinery is
impaired under prolonged excitatory synaptic activity in CHL12/2
synapses.
Discussion
We describe a novel role for CHL1 as a co-chaperone in the
presynaptic chaperone machinery consisting of Hsc70, CSP and
aSGT. The physiological significance of the interactions between
CHL1 containing chaperones and proteins of the synaptic vesicle
fusion machinery is underscored by our observations in CHL12/2
mice: CHL1 deficiency results in enhanced susceptibility of syntaxin
1B, SNAP25 and VAMP2 to degradation especially under stressful
conditions, such as exposure to heat or prolonged synaptic activity.
Syntaxin1B, SNAP25 and VAMP2 not only degrade faster in
CHL12/2 neurons, but also show reduced functionality under
stressful conditions manifested by decreased ability to bind to each
other.
VAMP2, SNAP25, and syntaxin 1B are ‘unstructured’ proteins
in a sense that they do not possess typical secondary structures
such as a-helixes and b-sheets. Nevertheless, exposure to
conditions close to pathological (42uC) results in a profound
aggregation of these proteins without any significant changes in
their overall random-coil structure. The latter observation is in
agreement with the notion that protein aggregation is intrinsic to
the common peptide backbone of any polypeptide chain [38].
Protein aggregation is often prevented by chaperones which bind
to the aggregating proteins [39], and our data indicate that CHL1
containing chaperones have a similar function with respect to
SNARE proteins both in vitro and in vivo, as indicated by increased
aggregation of VAMP2 and SNAP25 in CHL12/2 brains.
Accumulation of unfolded proteins may impose an increased load
on the chaperone machinery in CHL12/2 mice, which is also
suggested by a compensatory overexpression of chaperones in
CHL12/2 brains. Over-occupancy of chaperones in CHL12/2
mice may result in their unavailability for new targets, probably
accounting for a drastically lower chaperone activity towards such
artificial substrate as firefly luciferase.
Recombinant Hsc70, CSP and aSGT readily bind to each other
and form a trimeric complex in vitro [25]. We show that CHL1
splits Hsc70/CSP/aSGT complex into CHL1/CSP and CHL1/
Hsc70/aSGT complexes: CHL1 competes with CSP for binding
to Hsc70, which binds to the similar HPD tripeptide containing
sequences within CHL1ID and the J-domain of CSP [7,40]. On
the other hand, CHL1 binds to CSP via the HPD tripeptide
containing domain within CHL1ID, and this binding of CHL1 to
CSP interferes with the binding of CSP to Hsc70 or aSGT. The
latter observation suggests that CHL1 binds to the J-domain of
CSP containing the binding site for Hsc70. In agreement, in
synaptic vesicles and synaptic plasma membranes from CHL1+/+
brain tissue, Hsc70 and aSGT were found together in a complex
with CHL1 but not CSP, while CSP was found in a complex with
CHL1 but not Hsc70 or aSGT.
Interestingly, addition of recombinant Hsc70 to CHL12/2
synaptosomes strongly inhibited the reactivation of luciferase in
these preparations. A possible explanation for the dominant-
negative effect of recombinant Hsc70 is that, when added in
excess, it changes the stoichiometry of the chaperone complexes in
synaptosomes. In particular, it may promote dissociation of the
Hsc70/CSP/aSGT trimers, which are formed in the absence of
CHL1, and induce formation of aSGT/Hsc70 and CSP/Hsc70
dimers and Hsc70 monomers which have a considerably lower
chaperone activity towards luciferase when compared to Hsc70/
CSP/aSGT trimers [25].
Why should CHL1 disassemble the trimeric Hsc70/CSP/
aSGT complex? The physiological significance of this process is
underscored by analysis of chaperone activity in the presence of
non-native SNAP25 and VAMP2, which activated only CHL1/
and VAMP2. In indicated cases, non-native proteins were preincubated with CHL1ID/Hsc70/aSGT (R1) or CHL1ID/CSP (R2) complexes. Graphs show
quantitation of the binding of SNAP25 and VAMP2 to syntaxin1B 6 SEM (n=6) with the binding efficiency for both proteins in the native
conformation set to 100%. Native SNAP25 and VAMP2 form a complex with syntaxin1B, while exposure to heat of at least one component inhibits the
pull down efficiency. Preincubation of non-native SNAP25 with CHL1ID/Hsc70/aSGT and non-native VAMP2 with CHL1ID/CSP complexes increases
the efficiency of the SNARE complex assembly. *p,0.05, paired t-test (compared as indicated).
doi:10.1371/journal.pone.0012018.g005
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the Hsc70/CSP/aSGT complex. Importantly, ability of CSP to
function independently of Hsc70 in chaperone complexes has been
already shown previously [30,32].
CHL1 may enhance the affinity of the chaperones to non-native
SNAP25 and VAMP2, since recombinant CHL1ID interacts
directly with non-native but not native SNAP25 and VAMP2.
Because CSP and VAMP2 are localized to synaptic vesicles,
binding of CHL1 to VAMP2 most probably occurs in these
organelles. In agreement, the CHL1/VAMP2 complex is
disrupted after synaptic vesicle exocytosis which is accompanied
by redistribution of VAMP2 to the surface membrane. Further-
more, binding of CHL1 to CSP is favored by ATP, which should
be more abundant in non-stimulated synaptic boutons. In contrast,
SNAP25, accumulating at the synaptic surface plasma membrane,
most probably binds to CHL1 at the synaptic surface membrane.
In agreement, the association of CHL1 with SNAP25 is enhanced
following induction of synaptic vesicle exocytosis, i.e. when
SNARE complex proteins accumulate at the plasma membrane.
Formation of the CHL1/Hsc70/aSGT complex that binds
SNAP25 is favored by ADP, being present at higher levels in
stimulated synapses. Although CHL1/Hsc70/aSGT complexes
are formed at the plasma membrane, they can redistribute to
synaptic vesicles following internalization of CHL1 to these
organelles [7], an observation that would explain lower levels of
Hsc70 and aSGT in synaptic vesicles from CHL12/2 mice.
Unlike CSP deficient mice [27], CHL12/2 mice do not
exhibit gross neurodegenerative changes [2], suggesting that
CHL12/2 mice compensate for abnormal function of Hsc70,
CSP, and aSGT by increasing expression levels of these proteins
(Fig. S2, [7]). However, in the brains of CHL12/2 mice that
were maintained under normal housing conditions, SNARE
complex components were found to aggregate abnormally and
accumulate in lysosomes, suggesting that incorrectly folded
proteins gradually accumulate in the brain. We would like to
speculate that this phenomenon may relate to some of the
molecular abnormalities seen in slowly developing disorders of the
brain, such as schizophrenia, which is not associated with gross
neurological changes as well. The etiology of schizophrenia, a
disease linked to mutations in the CHL1 gene in humans [16,17],
not only includes a genetic predisposition but also an environ-
mental underpinning [41,42]. Changes in schizophrenic patients
progress slowly until they reach a critical threshold that is
manifested by the disease symptoms. Our observations are in line
with this hypothesis: small, genetically determined abnormalities in
synaptic transmission and synaptic protein turnover can aggravate,
especially following stressful conditions, and, depending on the
degree of aggravation, lead to irreversible changes in the
properties of information processing in the brains of humans
and mice carrying mutations in CHL1, thereby contributing to the
development of the disease. Independent of this hypothesis, our
observations show that the adhesion molecule CHL1 is a novel
regulator of the presynaptic chaperone machinery and thus a
decisive player in synaptic vesicle exocytosis in central nervous
system synapses.
Materials and Methods
Ethics Statement
All experiments were conducted in accordance with the German
and European Community laws on protection of experimental
animals, and all procedures used were approved by the responsible
committee of The State of Hamburg (permit ORG210).
Antibodies
The monoclonal antibody 2C2 reacting with the cytoplasmic
domains of L1 and CHL1 [2], a kind gift of Marty Grumet (Rutgers
University, Piscataway, NJ, USA), and polyclonal antibodies against
the extracellular domain of CHL1 and L1 [43] were as described.
Goat polyclonal antibodies against Hsc70 and synaptophysin were
purchased from Santa Cruz Biotechnology (Santa Cruz, California,
USA). We also used rabbit polyclonal antibodies against synapto-
physin (a kind gift of Reinhard Jahn, Max-Planck-Institute for
Biophysics, Go ¨ttingen, Germany). Monoclonal antibody (a6F)
against Na,K-ATPase and mouse monoclonal antibody against
SV2 were from the Developmental Studies Hybridoma Bank
(University of Iowa, USA), mouse monoclonal antibodies against c-
adaptin, SNAP25 and CSP were from BD Biosciences (San Jose, CA,
USA), rat monoclonal antibodies against Hsc70 were from Stressgen
(Victoria, BC, Canada), rabbit polyclonal antibodies against actin
were from Sigma (St. Louis, MO, USA), chicken polyclonal
antibodies against aSGT, rat monoclonal antibodies against Hsc70
and rabbit polyclonal antibodies to Lamp 2b were from Abcam
(Cambridge, UK), rabbit polyclonal antibodies against caspase-3
recognizing full-length non-active and cleaved active enzyme were
from Cell Signaling (Beverly, MA, USA), rabbit polyclonal antibodies
against syntaxin1B and mouse monoclonal antibodies against
SNAP25, and VAMP2 were from Synaptic Systems (Go ¨ttingen,
Germany), mouse monoclonal antibodies against GST were from
Novagen (Darmstadt, Germany), rabbit polyclonal antibodies against
neuronal class III b tubulin were from Covance (Berkeley, CA, USA).
Rabbit polyclonal antibodies against CSP, aSGT, and bSGT were a
kind gift from Guido Meyer (Max-Planck-Institute for Experimental
Medicine, Go ¨ttingen, Germany). Secondary antibodies against
rabbit, goat, chick and mouse immunoglobulins (Ig) coupled to horse
radish peroxidase (HRP), Cy2, Cy3 or Cy5 were from Dianova
(Hamburg, Germany).
DNA constructs
The construct encoding His6-tagged Hsc70 was a kind gift of
Christine Knuehl (Charite ´, Berlin, Germany). Constructs encod-
ing His6-tagged aSGT and GST-tagged Hsc70, CSP, aSGT and
Figure 6. CHL1ID/Hsc70/aSGT and CHL1ID/CSP chaperone complexes dissolve aggregates of SNAP25 and VAMP2, respectively. A –
CD spectra of native and heat-treated non-native SNAP25 and VAMP2. Exposure of the proteins to 42uC for 10 min did not affect the secondary
structure of the proteins, as revealed by almost identical CD spectra. A minor shift of the characteristic minimum towards 200 nm might indicate a
slight increase in their random coil structure content. B - Distribution of the radii of the protein complexes as measured by DLS. Data from 22
consecutive DLS measurements are shown with signal intensities displayed in pseudocolor. Heat exposure results in aggregation of SNAP25 and
VAMP2 (solid and dashed lines mark the size of particles formed by proteins in native and non-native conformations, respectively). CHL1ID, Hsc70 and
aSGT form a complex, which is larger than the complex formed by CHL1ID and CSP. The sizes of these complexes are marked by dotted lines (the
same data are shown in two columns for reference). Note, that SNAP25 and VAMP2 aggregates are dispersed in the presence of ATP by CHL1ID/
Hsc70/aSGT and CHL1ID/CSP, respectively. Protein aggregates are not dispersed in the absence of nucleotides or in the presence of ADP. Under these
conditions, the aggregates and CHL1ID/Hsc70/aSGT complex are seen as assemblies of two distinct sizes, with the smaller CHL1ID/CSP complex
being obscured by the larger aggregates, because the scattering intensity is proportional to the particle radius in the power of 3 [52]. SNAP25
aggregates are not dispersed by CHL1ID/CSP, and VAMP2 aggregates are not dispersed by CHL1ID/Hsc70/aSGT.
doi:10.1371/journal.pone.0012018.g006
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Planck-Institute for Experimental Medicine, Go ¨ttingen, Ger-
many). Constructs encoding His6-tagged SNAP25 and VAMP2
were kindly provided by Dirk Fasshauer (Max-Planck-Institute for
Biophysical Chemistry, Go ¨ttingen, Germany). His6-tagged L1ID
was donated by Melanie Richter (Pasquale lab, The Burnham
Institute, La Jolla, USA). His6-tagged CHL1ID was as described
[7]. Synapto-pHluorin construct was a kind gift of Gero
Miesenbo ¨ck (Yale University School of Medicine, New Haven,
CT, USA). Constructs encoding His6-tagged synaptophysin and
GST were from RZPD (Berlin, Germany) and Amersham
Pharmacia Biotech (Freiburg, Germany), respectively.
Recombinant proteins
Recombinant proteins were produced in E. coli, bound to Ni-
NTA agarose beads (QIAGEN, Hilden, Germany) via the His6 tag
or glutathione-agarose beads (Sigma) via the GST tag and used for
further experiments or purified according to the manufacturer’s
instructions. We also used SNAP25 from ProSpec (Rehovot,
Israel) and synaptophysin from Abnova (Taipei, Taiwan). CHL1-
Fc was as described [1]. Human Fc was from Dianova.
Preparation of homogenates and synaptosomes
Mouse brain homogenates were prepared in HOMO buffer
(1 mM MgCl2, 1 mM CaCl2, 1 mM NaHCO3, 5 mM Tris,
pH 7.4) containing 0.32 M sucrose (HOMO-A) and used for
synaptosome isolation as described [44]. All steps were performed
at 4uC. Briefly, homogenates were centrifuged at 1400 g for
10 min. The supernatant and pellet were resuspended in HOMO-
A buffer and centrifuged for 10 min at 700 g. The resulting
supernatants were combined and centrifuged at 17500 g for
15 min. The pellet was resuspended in HOMO-A buffer and
applied on the top of a step gradient with interfaces of 0.65 M,
0.85 M, 1 M, 1.2 M sucrose in HOMO buffer. The 700 g pellets
were combined, adjusted to 1 M sucrose in HOMO buffer and
layered on 1.2 M sucrose in HOMO buffer. HOMO-A buffer was
applied on the top of the gradient. The crude synaptosomal
fractions were collected at the 1 M/1.2 M interface after
centrifugation for 2 h at 100000 g and combined. The crude
synaptosomal fraction was again adjusted to 1 M sucrose and
layered on the top of the 1.2 M sucrose. HOMO-A buffer was
applied on the top of the gradient. After centrifugation for 2 h at
100000 g, synaptosomes were collected at the 1 M/1.2 M
interface, resuspended in HOMO-A buffer and pulled down by
centrifugation for 30 min at 100000 g.
Isolation and purification of synaptic vesicles
Synaptic vesicles were isolated essentially as described [45,46].
Briefly, 4 to 5 adult mouse brains were homogenized in 320 mM
Figure 7. CHL1 deficiency results in the increased degradation
of the SNARE complex proteins under elevated temperatures.
CHL1+/+ and CHL12/2 brain homogenates either freshly prepared or
pre-incubated at 30uC for 30 minutes were probed by Western blot with
the indicated antibodies. Note a more pronounced decline in the levels
of syntaxin1B, SNAP25 and VAMP2, but not synaptophysin in heat-
exposed CHL12/2 versus CHL1+/+ brain homogenates. Levels of
Hsc70, CSP and aSGT are similar or higher in CHL12/2 versus CHL1+/+
brain homogenates exposed to 30uC. Actin served as a loading control.
Graphs show mean optical density of the blots 6 SEM (n=6) with
optical density in non-treated homogenates set to 100%. *, 1 p,0.05,
paired t-test (CHL12/2 versus CHL1+/+ heat-treated brain homoge-
nates (*), and non-treated versus treated groups of the same genotype
(1) were compared).
doi:10.1371/journal.pone.0012018.g007
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10 min. All steps were performed at 4uC. The resulting supernatant
and pellet, which was resuspended in cold 320 mM sucrose/4 mM
HEPES, pH 7.4, were centrifuged for 15 min at 9200 g and 10500 g,
respectively. The resulting pellets (crude synaptosomal fraction) were
l y s e db yd i l u t i n gt h e mi n9v o l u m e so fi c e - c o l dH 2O and treated by
immediate adjustment by 1 M HEPES, pH 7.4, to a final
concentration of 7.5 mM HEPES. After incubation on ice for
30 min, the lysate was centrifuged at 25500 g for 20 min. The
supernatant was then centrifuged for 2 h at 130000 g. The resulting
pellet representing the crude synaptic vesicle fraction was resuspended
in 30 mM sucrose/4 mM HEPES, pH 7.4, homogenized by passage
through a 25-gauge needle, loaded on a continuous gradient of 50-
800 mM sucrose/4 mM HEPES, pH 7.4, and centrifuged at
100000 g for 5h. A broad band in the 200–400 mM sucrose region
containing synaptic vesicles was collected and pooled by centrifugation
at 250000 g for 2h. The pellet was resuspended in 30 mM sucrose/
4 mM HEPES, pH 7.4 and was found to be highly enriched in the
synaptic vesicle marker synaptophysin and negative for plasma
membrane marker Na,K-ATPase and endosomal marker EEA1 (not
shown).
Luciferase refolding assay
For the luciferase refolding assay, brain homogenates, synapto-
somes and synaptic vesicles (with a total protein concentration 0.6,
0.23 and 0.64 mg/ml, respectively) or recombinant His6-SGT, GST-
CSP, His6-Hsc70 or His6-CHL1ID (500 nM of each protein) were
used. Before analysis, brain homogenates were lysed in 1x Luciferase
cellculturelysisreagent(Promega,Madison,WI,USA)for15 minon
ice and centrifuged at 14000 g for 5 min to collectthe supernatants to
be used in the assay. Crude synaptosomal fraction was lysed for
30 min on ice by dilution with 9 volumes of ice-cold H2O, and
adjusted by 1M HEPES, pH 7.4, to a final concentration of 7.5 mM
HEPES. Recombinant luciferase (20 nM, QuantiLum Recombinant
Luciferase, Promega)was inactivated by incubation for 2 h at 25uCi n
8 M guanidine hydrochloride/2 mM DTT/30 mM Tris, pH 7.2.
Inactivated luciferase was then diluted 50-fold in 50 mM KCl/
30 mM HEPES, pH 7.4/2 mM DTT/3 mM MgCl2/1 mM ATP
and mixed (1:1) with the samples. The mixture was incubated for 1h
at 30uC and the activity of the reactivated luciferase was measured
u s i n gt h eP r o m e g al u c i f e r a s ea s s a ys y s t e ma n daT D - 2 0 / 2 0
luminometer (Turner Biosystems, Sunnyvale, CA, USA). The
activities of equal amounts of inactivated and native luciferase in
phosphate buffered saline (PBS, pH 7.4) were set to 0% and 100%,
respectively.
ATPase assay
ATPase activity was measured by estimating inorganic phos-
phate released during ATP hydrolysis. Recombinant SNAP25,
Figure 8. Levels of SNARE proteins are reduced in CHL12/2
versus CHL1+/+ neurons subjected to high levels of synaptic
activity. CHL1+/+ and CHL12/2 cultured hippocampal neurons were
stimulated with 50 mM PTX applied for 30 min. Lysates of non-treated
and PTX treated neurons were probed by Western blot with the
indicated antibodies. Graphs show mean optical density of the blots 6
SEM (n=6) with signals in non-treated neurons set to 100%. Note
reduced levels of SNAP25, syntaxin1B, and VAMP2, but not synapto-
physin in stimulated CHL12/2 versus stimulated CHL1+/+ neurons.
PTX application did not induce apoptosis as indicated by unchanged
levels of non-active and active caspase-3 in both genotypes. Tubulin
served as a loading control. *,1 p,0.05, paired t-test (PTX stimulated
CHL12/2 versus CHL1+/+ neurons (*), and PTX stimulated versus non-
stimulated neurons of the same genotype (1) were compared).
doi:10.1371/journal.pone.0012018.g008
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protein from CHL1+/+ and CHL12/2 brains were probed by Western blot with the indicated antibodies. Note that higher levels of VAMP2 and
SNAP25 are present in aggregates from CHL12/2 brain homogenates. Graph shows mean protein levels in aggregates 6 SEM (n=6) normalized to
the total protein level. *p,0.05, paired t-test. B - CHL1+/+ and CHL12/2 lysosomes were probed by Western blot with antibodies against the
lysosome associated proteins Lamp2b, SNAP25, VAMP2 and syntaxin1B. L1 served as a loading control. Graphs on the right show mean levels 6 SEM
of SNAP25, VAMP2 and syntaxin1B in lysosomes with levels in CHL1+/+ lysosomes set to 100%. Note similar levels of Lamp2b in CHL1+/+ and CHL12/2
lysosomes indicating similar efficiency of lysosome isolation. Graph (below) shows mean levels 6 SEM of acidic phosphatase activity in CHL1+/+ and
CHL12/2 lysosomes that was similar in lysosomes of both genotypes, again indicating that similar levels of lysosomes were isolated. Levels of SNAP25,
VAMP2, syntaxin1B, but not L1 are increased in CHL12/2 lysosomes. *p,0.05, paired t-test.
doi:10.1371/journal.pone.0012018.g009
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PLoS ONE | www.plosone.org 15 August 2010 | Volume 5 | Issue 8 | e12018Figure 10. Sustainability of the synaptic vesicle recycling machinery is reduced in CHL12/2 neurons. A -S y n t a x i n 1 B
immunoprecipitates (IP) from CHL1+/+ and CHL12/2 synaptosomes, treated with 4 mM or 90 mM K+, were probed by Western blot with
antibodies against synataxin1B, SNAP25 and VAMP2. Graphs show mean optical densities of the blots 6 SEM (n=6) with the levels of SNAP25 and
VAMP2 that co-immunoprecipitate with syntaxin1B from 4 mM K+ treated CHL1+/+ synaptosomes set to 100%. Exposure to 90 mM K+ reduces levels
of SNAP25 and VAMP2 that co-immunoprecipitate with syntaxin1B from CHL12/2 synaptosomes. *p,0.05, paired t-test (compared as indicated). B -
CHL1+/+ and CHL12/2 cultured hippocampal neurons that were either non-treated or pre-incubated with 50 mM PTX for 30 min were then
incubated with PTX for 10 min in the presence of FM1-43FX. After fixation, neurons were co-labeled with antibodies against SV2. Note FM1-43FX
loaded (yellow on overlay images, arrows) and non-loaded (red on overlay images, arrowheads) SV2 positive synaptic boutons. Note, that FM1-43FX
non-loaded synapses are present in all groups. However, number of FM1-43FX non-loaded synapses is increased and levels of FM1-43FX in FM1-43FX
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25 mM HEPES buffer, pH 7.5, containing 150 mM KCl, 2 mM
DTT, and 5 mM MgCl2. Various combinations of recombinant
GST-tagged CSP and His6-tagged aSGT, Hsc70 and CHL1ID
(3 mM of each protein) were incubated with heat-treated non-
native or native SNAP25, synaptophysin or VAMP2 (0.24 mM for
each protein) in 20 mM HEPES buffer, pH 7.5, containing
40 mM KCl, 1 mM (NH4)2SO4, 2 mM MgCl2, 500 mM DTT,
1.2 mM ATP for 1 h at 30uC. Inorganic phosphate released from
ATP was measured using the Malachite green phosphate detection
kit (R&D Systems, Wiesbaden-Nordenstadt, Germany).
Pull down assay
In a typical pull down experiment, beads with the bound ‘‘prey’’
protein were incubated with the purified potential binding
partners or control proteins overnight at 4uC in 3% BSA, 0.l%
Tween 20, 0.1 mM phenylmethansulfonylfluoride (PMSF) and
1 mM ADP or ATP in PBS, pH 7.5. After washing with PBS
containing 1% BSA, 0.1 mM PMSF, 1 mM ADP (or ATP), 0.1%
Tween 20, pH 7.5, protein complexes were eluted from the beads
by incubation in Laemmli buffer and analyzed by SDS-PAGE and
Western blot using appropriate antibodies.
Gel electrophoresis and immunoblotting
Proteins were separated by 8–16% SDS-PAGE and electro-
blotted onto 0.2 mm nitrocellulose transfer membrane PROTRAN
(Schleicher & Schuell, Dassel, Germany) overnight at 40 V. To
analyze protein complexes, samples containing synaptic vesicles
and plasma membranes were lysed for 1 h at room temperature in
50 mM Tris-HCl buffer, pH 7.4, containing 1% Triton X-100,
1m MN a 2P2O7, 1 mM NaF, 2 mM NaVO4, 0.1 mM PMSF and
complete protease inhibitor cocktail (Roche Diagnostics). After
removal of Triton X-100 from the samples using Bio-Beads SM-2
(Bio-Rad, Hercules, CA, USA), 2-mercaptoethanol was added to
the samples to increase protein solubility and prevent protein
aggregation. Proteins were then separated by 6% PAGE and
electroblotted onto 0.2 mm nitrocellulose transfer membrane
PROTRAN (Schleicher & Schuell) overnight at 40 V. Immuno-
blots were incubated with appropriate primary antibodies followed
by incubation with peroxidase-labeled secondary antibodies and
visualized using Super Signal West Pico reagents (Pierce Chemical
Co., Rockford, IL, USA) on BIOMAX film (Sigma). Molecular
weight markers were prestained protein standards (Bio-Rad) and
apoferritin (Sigma). Blots were quantified using TINA 2.09
software (University of Manchester, UK).
Isolation of lysosomes
Lysosomes were isolated on a discontinuous OptiPrep gradient
using the lysosome isolation kit (Sigma). Fractions were collected at
the interfaces of the OptiPrep gradient and assayed for the activity
of acid phosphatase, a hydrolase highly accumulated in lysosomes,
using the acid phosphatase assay kit (Sigma). The fraction
containing the highest acid phosphatase activity (at the interface
between 12% and 16% of the OptiPrep) was taken as purified
lysosomes. Western blot analysis confirmed that this lysosomal
fraction was highly enriched in lysosomal protein Lamp2b and
negative for trans-Golgi marker protein c-adaptin.
Isolation of protein aggregates
Protein aggregates were isolated by differential centrifugation by
modifying a described protocol [47]. Adult mouse brains were
homogenized in extraction buffer (60 mM HEPES, pH 7.4, 0.1%
Triton X-100, 100 mM NaCl, 0.5 mM PMSF, 0.1 mM DTT and
complete protease inhibitor cocktail (Roche Diagnostics)) and
centrifuged at 680 g for 10 min. Resulting supernatants were
centrifuged at 100000 g for 1 h. Pellets were resuspended in
extraction buffer, sonificated and centrifuged at 17000 g for
30 min. Resulting pellets were resuspended in extraction buffer
and centrifuged at 5000 g for 30 min. Collected pellets containing
protein aggregates were analyzed by Western blot analysis. All
steps were performed at 4uC.
Co-immunoprecipitation
Homogenates from adult mouse brains were prepared in 50 mM
Tris-HCl buffer, pH 7.5, containing 0.32 M sucrose, 1 mM of CaCl2,
1m MM g C l 2,a n d1m MN a H C O 3. Samples containing 1 mg of
total protein were lysed for 40 min at 4uC with lysis buffer, pH 7.5,
containing 50 mM Tris-HCl, 150 mM NaCl, 1% Nonidet P-40,
1m M N a 2P2O7,1 m MN a F ,1 m ME D T A ,2 m MN a 3VO4,
0.1 mM PMSF and complete protease inhibitor cocktail (Roche
Diagnostics). To analyze co-immunoprecipitation of CSP and
VAMP2, the lysis buffer was supplemented with 1% SDS. After lysis,
SDS was removed using Detergent-OUT SDS removal kit (Merck,
Darmstadt, Germany). Samples were centrifuged for 5 min at 14000g
at 4uC. Supernatants were cleared with protein A/G-agarose beads
(Santa Cruz Biotechnology) (3 h at 4uC) and incubated with
corresponding antibodies or non-specific control IgG (overnight,
4uC), followed by precipitation with protein A/G-agarose beads (1 h,
4uC). The beads were washed 3 times with lysis buffer, 2 times with
TBS and boiled in Laemmli buffer. Eluted material was used for
Western blot analysis.
Circular dichroism (CD) spectroscopy
CD spectra were recorded at 20uCu s i n gaJ a s c oJ - 7 1 5
spectropolarimeter (Jasco, Gross-Umstadt, Germany) equipped with
a temperature-regulated sample chamber. A 1 mm optical path
length quartz cell was used to obtain spectra in the far UV region (190
to 260 nm) at a protein concentration of 0.63 mMf o rS N A P 2 5a n d
1 mMfo rV A M P 2i n1 0m MM g S O 4/4 mM DTT/50 mM HEPES,
pH 7.5. The CD spectra were acquired at a scan speed of 20 nm/min
and a step resolution of 0.1 nm. For each experiment, 20 individual
scans were averaged, and background spectra were subtracted.
Dynamic light scattering (DLS) measurements
Dynamic light scattering measurements were made using the
DIMINIGON-A DLS device (Dierks und Partner, Hamburg,
Germany)withaHe-Nelaserprovidingradiationwithawavelength
of 658 nm and an output power in the range of 10–50 mW. The
samples (40 ml) were placed in a quartz cuvette and measured at a
constant temperature of 20uC using an autopilot function
accumulating 22 measurements per sample at every 20 s, with a
wait time of 1 s.
Enzyme-linked immunosorbent assay (ELISA)
CHL1ID (1.9 mM) was immobilized on the plastic surface of
MaxiSorp 96 well plates (Nunc, Roskilde, Denmark) overnight
loaded synapses are reduced in CHL12/2 versus CHL1+/+ neurons pre-treated with PTX. Graphs show mean FM1-43FX and SV2 fluorescence
levels 6 SEM in SV2 accumulations (N.30 images of neurons with n.200 SV2 positive synaptic boutons per image were analyzed in each group).
*,1 p,0.05, t-test (PTX stimulated CHL12/2 versus CHL1+/+ neurons (*), and PTX stimulated versus non-stimulated neurons of the same genotype
(1) were compared).
doi:10.1371/journal.pone.0012018.g010
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containing 0.05% Tween 20, blocked with 1% BSA in PBS for 1 h
at room temperature, and incubated overnight at 4uC with
SNAP25 (4 mM) and VAMP2 (6 mM), in PBS containing 0.05%
Tween 20 and 0.1% BSA. SNAP25 and VAMP2 were either non-
treated or pre-treated by exposure to 42uC as described in ATPase
assay section. Wells were washed 3 times with PBS containing
0.05% Tween 20. Bound proteins were detected with antibodies
against SNAP25 and VAMP2 followed by HRP-conjugated
secondary antibodies. Protein binding was visualized by detecting
HRP with the OPD reagent (Pierce, Rockford, IL, USA) that
resulted in a colored product. The amount of colored product was
quantified using an ELISA reader at 406 nm.
Cultures of hippocampal neurons
Cultures of hippocampal neurons were prepared from 1- to 3-
day-old mice. Neurons were grown for 14–21 days in Neurobasal
A medium (Invitrogen, Carlsbad, CA, USA) supplemented with
2% B-27 (Invitrogen), glutamine (Invitrogen) and FGF-2 (2 ng/ml,
R&D Systems) on glass coverslips (for live imaging and
immunocytochemsitry) or in 6-well plastic plates (for biochemistry)
coated with poly-D-lysine (100 mg/ml). For live cell imaging,
neurons were transfected 12 days after plating using Lipofectamine
2000 (Invitrogen) according to the manufacturer’s instructions.
Immunofluorescence labeling
Immunolabeling was performed essentially as described [48].
All steps were performed at room temperature. Neurons were
fixed for 15 min in 4% formaldehyde in PBS, pH 7.4, permea-
bilized with 0.25% Triton X-100 in PBS, pH 7.4 for 5 min and
blocked with 1% BSA in PBS for 20 min. Primary antibodies were
applied in 1% BSA in PBS for 2 hours and detected with
corresponding secondary antibodies applied for 45 min. Cover-
slips were embedded in Aqua-Poly/Mount (Polysciences Inc.,
Warrington, PA, USA). Images were acquired at room temper-
ature using a confocal laser scanning microscope LSM510.
Loading of FM1-43FX in synaptic boutons
Synaptic boutons of cultured hippocampal neurons [49] were
loaded with FM1-43FX by incubating neurons for 10 min in the
medium containing FM1-43FX (15 mM) (Invitrogen) in the
presence of 50 mM PTX (Tocris, Ballwin, MO, USA).
Immunofluorescence and FM uptake quantification
In fixed and permeabilized neurons, labeling with SV2
antibodies was used to identify synaptic boutons that were defined
as SV2 accumulations with a mean intensity of at least 30% higher
than background. The background was defined as the mean
intensity of pixels in the square 30x30 pixel area located in the
vicinity of the synaptic bouton in the part of the image devoid of
synaptic boutons. Synaptic boutons were outlined using a
threshold function of the ImageJ software (National Institute of
Health, Bethesda, MD, USA). Within the outlines, mean
intensities of the SV2 labeling and FM dye were measured and
expressed in arbitrary units defined as 8 bit pixel values of the gray
scale image. In each experiment, images were acquired using
identical settings and the same threshold was used for all groups.
VAMP2-pHluorin fluorescence quantification
During recordings, live hippocampal neurons transfected in
vitro with VAMP2-pHluorin were maintained at room tempera-
ture in modified Tyrode solution (150 mM NaCl, 4 mM KCl,
2 mM MgCl2, 10 mM glucose, 10 mM HEPES and 2 mM CaCl2
(pH 7.4, ,310 mOsm)) or 47 mM K+ buffer (modified Tyrode
solution containing equimolar substitution of KCl for NaCl) to
induce synaptic vesicle exo- and endocytosis [50]. All procedures
were performed in the presence of 10 mM CNQX and 50 mM AP-
5 to prevent recurrent activation elicited by AMPA and NMDA
receptors, respectively. Changes in VAMP2-pHluorin fluorescence
were monitored with time by acquiring images using a laser
scanning microscope LSM510 (Zeiss, Jena, Germany) with 1 s
intervals. With these recorded time series, synaptic boutons were
identified as accumulations of VAMP2-pHluorin fluorescence that
appeared following the first application of 47 mM K+ and were at
least 30% brighter in intensity than the background VAMP2-
pHluorin fluorescence before application of 47 mM K+. VAMP2-
pHluorin clusters were outlined using ImageJ when VAMP2-
pHluorin fluorescence reached the maximum following the first
application of 47 mM K+. These outlines were then used to
measure VAMP2-pHluorin fluorescence intensity on all images
that were recorded before, during and after the first and second
application of 47 mM K+.
Statistical analysis
Statistical significance of the differences observed by Western
blot analysis and by luciferase reactivation and ATPase assays was
analyzed using the paired t-test or repeated measures ANOVA
Dunnett’s multiple comparison test as indicated in the figure
legends. Differences in FM1-43 uptake were compared by the t-
test. Numbers of observations and compared groups are indicated
in Figure legends.
Supporting Information
Figure S1 Hsc70 and CSP, but not alphaSGT and CHL1
possess intrinsic ATPase and protein refolding activities. A -
ATPase activity estimated by measuring free inorganic phosphate
released from ATP in the presence of recombinant Hsc70, CSP,
alphaSGT, or CHL1ID and heat-treated recombinant luciferase.
Graph shows mean 6 SEM (n=6). Note, that Hsc70 and CSP but
not CHL1ID and alphaSGT possess detectable intrinsic ATPase
activity. *,+p,0.05, paired t-test (when compared to the group
incubated with Hsc70 (*), or with CSP (+)). B - Graph shows mean
levels of activity 6 SEM (n=6) of the luciferase, that was
reactivated in the presence of recombinant Hsc70, CSP,
alphaSGT, or CHL1ID. Values were normalized to the luciferase
reactivation levels in the presence of Hsc70. Note, that luciferase
reactivation in the presence of CHL1ID and alphaSGT was lower
than in the presence of Hsc70 and CSP. Taking into account that
CHL1ID and alphaSGT do not show detectable ATPase activity,
luciferase reactivation in the presence of these two proteins most
probably occurs via spontaneous refolding of luciferase.
*,+p,0.05, paired t-test (when compared to the group incubated
with Hsc70 (*), or with CSP (+)).
Found at: doi:10.1371/journal.pone.0012018.s001 (0.06 MB TIF)
Figure S2 Levels of alphaSGT are reduced in CHL12/2
synaptosomes. CHL1+/+ and CHL12/2 brain homogenates
and synaptosomes isolated from CHL1+/+ and CHL12/2
brains were probed by Western blot with antibodies against
alphaSGT and betaSGT. Representative blots are shown. Graphs
show mean optical densities of the blots 6 SEM (n=6) with
optical density for CHL1+/+ probes set to 100%. Note that levels
of alphaSGT, but not betaSGT are increased in CHL12/2
versus CHL1+/+ brain homogenates and decreased in CHL12/2
versus CHL1+/+ synaptosomes. *p,0.05, paired t-test.
Found at: doi:10.1371/journal.pone.0012018.s002 (0.21 MB TIF)
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recycling in CHL12/2 cultured hippocampal neurons. To
directly analyze the impact of CHL1 deficiency on synaptic
vesicle recycling, we transfected cultured hippocampal neurons
with a pH-sensitive green-fluorescent protein fused to the lumenal
domain of VAMP2 (VAMP2-pHluorin), providing an optical
probe to follow synaptic vesicle exo- and endocytosis in real time
[53]: Synaptic vesicle exocytosis exposes pHluorin to the
fluorescence-permissive culture medium, while pHluorin endocy-
tosis to synaptic vesicles results in quenching of fluorescence in the
acidified environment of the vesicle lumen. Neurons were
challenged twice with 47 mM K+ for 90 s with a recovery in
4m MK + following each application of 47 mM K+. Diagrams
(left) show mean levels 6 SEM of synapto-pHluorin fluorescence
intensities in synaptic boutons as a function of time. The values
were normalized to the synapto-pHluorin fluorescence intensity
before stimulation. Black bars indicate time of 47 mM K+
application. Time lapse recordings of axons of the transfected
neurons showed that in CHL1+/+ neurons both applications of
47 mM K+ resulted in similar increases in VAMP2-pHluorin
fluorescence in synaptic boutons, indicating that comparable
numbers of synaptic vesicles were exocytosed. Substitution of
47 mM K+ with 4 mM K+ resulted in a gradual decline in
VAMP2-pHluorin fluorescence intensity, indicating synaptic
vesicle endocytosis. In contrast to CHL1+/+ neurons, CHL12/2
neurons responded with a pronounced increase in VAMP2-
pHluorin fluorescence levels in synaptic boutons only to the first
application of 47 mM K+, while the second response was strongly
reduced. Graph (right) shows mean ratio 6 SEM of the
amplitudes (Amp) of synapto-pHluorin fluorescence intensity
increase in response to the first and second application of
47 mM K+.*p ,0.05, t-test (n=10 synapses from five CHL1+/+
neurons and n=20 synapses from six CHL12/2 neurons were
analyzed). A reduction in the second response could be due to the
impaired endocytosis of synaptic vesicles in CHL12/2 synaptic
boutons following the first stimulus that would result in
unavailability of synaptic vesicles for exocytosis during the second
stimulus. Indeed, the endocytosis of VAMP2-pHluorin following
the first application of 47 mM K+ was slower and more
incomplete in CHL12/2 versus CHL1+/+ synaptic boutons in
agreement with our previous report [7]. However, 81 +/2 5.2%
of VAMP2-pHluorin fluorescence was quenched in CHL12/2
synaptic boutons by the end of the recovery time after the first
stimulus indicating that impaired endocytosis in CHL12/2
synaptic boutons may account for only 20% reduction in the
response to the second stimulus. In fact, the second response was
reduced by 81 +/2 17% when compared to the first one.
Furthermore, the changes in responses defined as the ratio of the
amplitudes of VAMP2-pHluorin fluorescence increase after the
first and second application of 47 mM K+ did not correlate with
the efficiency of VAMP2-pHluorin endocytosis following the first
stimulus (correlation coefficient=20.083) indicating that the
impairment in synaptic vesicle exocytosis in response to the
second stimulus cannot be explained only by impaired synaptic
vesicle endocytosis after the first stimulus. Interestingly, the
amplitude of the first response was slightly higher in CHL12/2
versus CHL1+/+ neurons, possibly due to increased levels of CSP
in CHL12/2 synaptic boutons [54]. This observation is in
agreement with the previously reported enhanced basal synaptic
transmission in CHL12/2 mice [9].
Found at: doi:10.1371/journal.pone.0012018.s003 (0.10 MB TIF)
Table S1 Changes in ATPase activity in different combinations
of CHL1ID, Hsc70, CSP and alphaSGT in the presence of non-
native versus native SNAP25, VAMP2 or synaptophysin.
Recombinant CHL1ID, Hsc70, CSP and alphaSGT in the
indicated combinations were incubated with heat-treated non-
native and native SNAP25, VAMP2 or synaptophysin. Table
shows ATPase activity in the presence of non-native proteins
normalized to ATPase activity in the presence of native proteins
set to 100%. ATPase activity values observed in the presence of
non-native proteins that are statistically different (paired t-test,
n$6) from the values obtained for native proteins are highlighted
in yellow. ND - not determined.
Found at: doi:10.1371/journal.pone.0012018.s004 (0.32 MB TIF)
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